» Articles » PMID: 16225786

The HIV Infection and Immune Activation: "to Fight and Burn"

Overview
Date 2005 Oct 18
PMID 16225786
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Immune activation, a normal immune reaction to pathogens, is now recognized as a major driving force of the CD4 T-cell depletion and immune disorders caused by HIV. By contrast, the natural hosts of its ancestor virus, simian immunodeficiency virus, have adapted to this virus by blocking immune activation and remaining healthy. This review will focus on evidence demonstrating how immune activation associated with HIV infection exhausts immune defenses to HIV as well as the immune system, thus leading to immunosenescence and immunodeficiency, and how treatment can disrupt this vicious and ultimately fatal circle.

Citing Articles

Inflammatory and Immune Mechanisms for Atherosclerotic Cardiovascular Disease in HIV.

Hmiel L, Zhang S, Obare L, Santana M, Wanjalla C, Titanji B Int J Mol Sci. 2024; 25(13).

PMID: 39000373 PMC: 11242562. DOI: 10.3390/ijms25137266.


Soybean-derived Bowman-Birk Inhibitor (BBI) Inhibits HIV Replication in Macrophages.

Ma T, Zhou R, Wang X, Li J, Sang M, Zhou L Sci Rep. 2016; 6:34752.

PMID: 27734899 PMC: 5062087. DOI: 10.1038/srep34752.


Mitral Annular and Coronary Artery Calcification Are Associated with Mortality in HIV-Infected Individuals.

Lange D, Glidden D, Secemsky E, Ordovas K, Deeks S, Martin J PLoS One. 2015; 10(7):e0130592.

PMID: 26132465 PMC: 4488486. DOI: 10.1371/journal.pone.0130592.


Taking stock of infections and antibiotic resistance in the elderly and long-term care facilities: A survey of existing and upcoming challenges.

Augustine S, Bonomo R Eur J Microbiol Immunol (Bp). 2014; 1(3):190-7.

PMID: 24516724 PMC: 3906614. DOI: 10.1556/EuJMI.1.2011.3.2.


HIV-associated lipodystrophy: impact of antiretroviral therapy.

Guaraldi G, Stentarelli C, Zona S, Santoro A Drugs. 2013; 73(13):1431-50.

PMID: 24002702 DOI: 10.1007/s40265-013-0108-1.


References
1.
Clerici M, Stocks N, Zajac R, Boswell R, Lucey D, Via C . Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J Clin Invest. 1989; 84(6):1892-9. PMC: 304069. DOI: 10.1172/JCI114376. View

2.
Gougeon M, Lecoeur H, Dulioust A, Enouf M, Crouvoiser M, Goujard C . Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. J Immunol. 1996; 156(9):3509-20. View

3.
Algeciras-Schimnich A, Vlahakis S, Villasis-Keever A, Gomez T, Heppelmann C, Bou G . CCR5 mediates Fas- and caspase-8 dependent apoptosis of both uninfected and HIV infected primary human CD4 T cells. AIDS. 2002; 16(11):1467-78. DOI: 10.1097/00002030-200207260-00003. View

4.
Hazenberg M, Hamann D, Schuitemaker H, Miedema F . T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock. Nat Immunol. 2001; 1(4):285-9. DOI: 10.1038/79724. View

5.
Algeciras A, Dockrell D, Lynch D, Paya C . CD4 regulates susceptibility to Fas ligand- and tumor necrosis factor-mediated apoptosis. J Exp Med. 1998; 187(5):711-20. PMC: 2212167. DOI: 10.1084/jem.187.5.711. View